These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22340708)

  • 41. Increased serum levels of CD95 in Alzheimer's disease.
    Richartz E; Noda S; Schott K; Günthner A; Lewczuk P; Bartels M
    Dement Geriatr Cogn Disord; 2002; 13(3):178-82. PubMed ID: 11893840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease. Specific differences to vascular dementia.
    Eckert A; Oster M; Zerfass R; Hennerici M; Müller WE
    Dement Geriatr Cogn Disord; 2001; 12(2):98-105. PubMed ID: 11173881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alix: A Candidate Serum Biomarker of Alzheimer's Disease.
    Sun Y; Hua J; Chen G; Li J; Yang J; Gao H
    Front Aging Neurosci; 2021; 13():669612. PubMed ID: 34211388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3.
    Yang H; Oh CK; Amal H; Wishnok JS; Lewis S; Schahrer E; Trudler D; Nakamura T; Tannenbaum SR; Lipton SA
    Sci Adv; 2022 Dec; 8(50):eade0764. PubMed ID: 36516243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera.
    Nagele E; Han M; Demarshall C; Belinka B; Nagele R
    PLoS One; 2011; 6(8):e23112. PubMed ID: 21826230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation.
    Yao F; Zhang K; Zhang Y; Guo Y; Li A; Xiao S; Liu Q; Shen L; Ni J
    Front Neurol; 2018; 9():1158. PubMed ID: 30671019
    [No Abstract]   [Full Text] [Related]  

  • 47. Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease.
    Pérez MJ; Ponce DP; Osorio-Fuentealba C; Behrens MI; Quintanilla RA
    Front Neurosci; 2017; 11():553. PubMed ID: 29056898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of Cell Cycle Proteins of Peripheral Lymphocytes in Patients with Alzheimer's Disease.
    Kim H; Kwon YA; Ahn IS; Kim S; Kim S; Jo SA; Kim DK
    Psychiatry Investig; 2016 Jan; 13(1):127-34. PubMed ID: 26766955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary Alterations in Impaired Mitochondrial Dynamics Due to Neurodegeneration.
    Ashraf GM; Chatzichronis S; Alexiou A; Firdousi G; Kamal MA; Ganash M
    Front Aging Neurosci; 2022; 14():893018. PubMed ID: 35898328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G1/S checkpoint proteins in peripheral blood lymphocytes are potentially diagnostic biomarkers for Alzheimer's disease.
    Song J; Wang S; Tan M; Jia J
    Neurosci Lett; 2012 Sep; 526(2):144-9. PubMed ID: 22922216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers.
    Tan M; Wang S; Song J; Jia J
    Neurosci Lett; 2012 May; 516(2):226-31. PubMed ID: 22503900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered Metabolism and DAM-signatures in Female Brains and Microglia with Aging.
    Cleland NRW; Potter GJ; Buck C; Quang D; Oldham D; Neal M; Saviola A; Niemeyer CS; Dobrinskikh E; Bruce KD
    bioRxiv; 2023 Nov; ():. PubMed ID: 38076915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease.
    Sousa T; Moreira PI; Cardoso S
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the association between
    Liu J; Huang J; Zhao Y; Pan H; Wang Y; Liu Z; Xu Q; Sun Q; Tan J; Yan X; Li J; Tang B; Guo J
    Front Neurol; 2023; 14():1133449. PubMed ID: 36908591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of Rare Genetic Variants to Identify Candidate Modifier Genes Underlying Neurological Manifestations in Neurofibromatosis 1 Patients.
    Tang J; Li N; Li G; Wang J; Yu T; Yao R
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of Mitochondrial Dynamics in Cocaine's Neurotoxicity.
    Wen S; Aki T; Funakoshi T; Unuma K; Uemura K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease.
    Villavicencio Tejo F; Quintanilla RA
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of Fis1 impairs proteostasis during skeletal muscle aging in Drosophila.
    Lee TT; Chen PL; Su MP; Li JC; Chang YW; Liu RW; Juan HF; Yang JM; Chan SP; Tsai YC; von Stockum S; Ziviani E; Kamikouchi A; Wang HD; Chen CH
    Aging Cell; 2021 Jun; 20(6):e13379. PubMed ID: 34061429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Significance of the Fission1/Parkin Ratio for Sepsis: A Prospective Cohort Study.
    Huang W; Wang X; Zhang H; Wang G; Liu D
    Front Med (Lausanne); 2021; 8():642749. PubMed ID: 34055831
    [No Abstract]   [Full Text] [Related]  

  • 60. Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?
    Bell SM; Barnes K; De Marco M; Shaw PJ; Ferraiuolo L; Blackburn DJ; Venneri A; Mortiboys H
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33440662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.